US Stock MarketDetailed Quotes

APTO Aptose Biosciences

Watchlist
  • 1.1300
  • -0.0200-1.74%
Close May 22 16:00 ET
  • 1.1800
  • +0.0500+4.42%
Post 17:02 ET
18.43MMarket Cap-185P/E (TTM)

Aptose Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-30.76%9.76M
22.90%52.36M
16.57%12.13M
16.51%11.68M
35.41%14.45M
22.57%14.1M
-34.91%42.6M
-57.27%10.4M
-11.74%10.03M
-20.87%10.67M
Selling and administrative expenses
-37.17%3.31M
7.68%15.54M
-16.79%3M
-0.26%3.42M
16.52%3.86M
28.81%5.27M
-25.31%14.43M
-12.10%3.61M
-5.05%3.42M
-8.59%3.31M
-General and administrative expense
-37.17%3.31M
7.68%15.54M
-16.79%3M
-0.26%3.42M
16.52%3.86M
28.81%5.27M
-25.31%14.43M
-12.10%3.61M
-5.05%3.42M
-8.59%3.31M
Research and development costs
-26.85%6.45M
30.89%36.77M
34.53%9.12M
25.51%8.26M
44.15%10.58M
19.18%8.81M
-38.92%28.09M
-66.47%6.78M
-14.77%6.58M
-25.33%7.34M
Depreciation amortization depletion
-66.67%6K
-39.51%49K
-55.56%8K
-58.33%10K
-42.86%12K
0.00%18K
-41.30%81K
-47.06%18K
-31.43%24K
-40.00%21K
-Depreciation and amortization
-66.67%6K
-39.51%49K
-55.56%8K
-58.33%10K
-42.86%12K
0.00%18K
-41.30%81K
-47.06%18K
-31.43%24K
-40.00%21K
Operating profit
30.76%-9.76M
-22.90%-52.36M
-16.57%-12.13M
-16.51%-11.68M
-35.41%-14.45M
-22.57%-14.1M
34.91%-42.6M
57.27%-10.4M
11.74%-10.03M
20.87%-10.67M
Net non-operating interest income expense
-71.33%121K
46.07%1.15M
-57.36%171K
-8.66%232K
193.69%326K
1,818.18%422K
738.30%788K
1,722.73%401K
1,054.55%254K
382.61%111K
Non-operating interest income
-71.33%121K
46.07%1.15M
-57.36%171K
-8.66%232K
193.69%326K
1,818.18%422K
738.30%788K
1,722.73%401K
1,054.55%254K
382.61%111K
Other net income (expense)
50.00%-1K
77.78%-2K
-50.00%1K
140.00%2K
0.00%-3K
33.33%-2K
-800.00%-9K
0.00%2K
-225.00%-5K
40.00%-3K
Gain on sale of security
50.00%-1K
77.78%-2K
-50.00%1K
140.00%2K
0.00%-3K
33.33%-2K
-800.00%-9K
0.00%2K
-225.00%-5K
40.00%-3K
Income before tax
29.51%-9.64M
-22.44%-51.21M
-19.55%-11.96M
-17.08%-11.45M
-33.73%-14.13M
-19.12%-13.68M
36.01%-41.82M
58.89%-10M
13.73%-9.78M
21.57%-10.57M
Income tax
Net income
29.51%-9.64M
-22.44%-51.21M
-19.55%-11.96M
-17.08%-11.45M
-33.73%-14.13M
-19.12%-13.68M
36.01%-41.82M
58.89%-10M
13.73%-9.78M
21.57%-10.57M
Net income continuous Operations
29.51%-9.64M
-22.44%-51.21M
-19.55%-11.96M
-17.08%-11.45M
-33.73%-14.13M
-19.12%-13.68M
36.01%-41.82M
58.89%-10M
13.73%-9.78M
21.57%-10.57M
Minority interest income
Net income attributable to the parent company
29.51%-9.64M
-22.44%-51.21M
-19.55%-11.96M
-17.08%-11.45M
-33.73%-14.13M
-19.12%-13.68M
36.01%-41.82M
58.89%-10M
13.73%-9.78M
21.57%-10.57M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
29.51%-9.64M
-22.44%-51.21M
-19.55%-11.96M
-17.08%-11.45M
-33.73%-14.13M
-19.12%-13.68M
36.01%-41.82M
58.89%-10M
13.73%-9.78M
21.57%-10.57M
Basic earnings per share
67.12%-0.73
-11.47%-7.58
11.66%-1.44
-10.69%-1.76
-31.98%-2.27
-23.33%-2.22
37.90%-6.8
59.75%-1.63
18.46%-1.59
23.56%-1.72
Diluted earnings per share
67.12%-0.73
-11.47%-7.58
11.66%-1.44
-10.69%-1.76
-31.98%-2.27
-23.33%-2.22
37.90%-6.8
59.75%-1.63
18.46%-1.59
23.56%-1.72
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -30.76%9.76M22.90%52.36M16.57%12.13M16.51%11.68M35.41%14.45M22.57%14.1M-34.91%42.6M-57.27%10.4M-11.74%10.03M-20.87%10.67M
Selling and administrative expenses -37.17%3.31M7.68%15.54M-16.79%3M-0.26%3.42M16.52%3.86M28.81%5.27M-25.31%14.43M-12.10%3.61M-5.05%3.42M-8.59%3.31M
-General and administrative expense -37.17%3.31M7.68%15.54M-16.79%3M-0.26%3.42M16.52%3.86M28.81%5.27M-25.31%14.43M-12.10%3.61M-5.05%3.42M-8.59%3.31M
Research and development costs -26.85%6.45M30.89%36.77M34.53%9.12M25.51%8.26M44.15%10.58M19.18%8.81M-38.92%28.09M-66.47%6.78M-14.77%6.58M-25.33%7.34M
Depreciation amortization depletion -66.67%6K-39.51%49K-55.56%8K-58.33%10K-42.86%12K0.00%18K-41.30%81K-47.06%18K-31.43%24K-40.00%21K
-Depreciation and amortization -66.67%6K-39.51%49K-55.56%8K-58.33%10K-42.86%12K0.00%18K-41.30%81K-47.06%18K-31.43%24K-40.00%21K
Operating profit 30.76%-9.76M-22.90%-52.36M-16.57%-12.13M-16.51%-11.68M-35.41%-14.45M-22.57%-14.1M34.91%-42.6M57.27%-10.4M11.74%-10.03M20.87%-10.67M
Net non-operating interest income expense -71.33%121K46.07%1.15M-57.36%171K-8.66%232K193.69%326K1,818.18%422K738.30%788K1,722.73%401K1,054.55%254K382.61%111K
Non-operating interest income -71.33%121K46.07%1.15M-57.36%171K-8.66%232K193.69%326K1,818.18%422K738.30%788K1,722.73%401K1,054.55%254K382.61%111K
Other net income (expense) 50.00%-1K77.78%-2K-50.00%1K140.00%2K0.00%-3K33.33%-2K-800.00%-9K0.00%2K-225.00%-5K40.00%-3K
Gain on sale of security 50.00%-1K77.78%-2K-50.00%1K140.00%2K0.00%-3K33.33%-2K-800.00%-9K0.00%2K-225.00%-5K40.00%-3K
Income before tax 29.51%-9.64M-22.44%-51.21M-19.55%-11.96M-17.08%-11.45M-33.73%-14.13M-19.12%-13.68M36.01%-41.82M58.89%-10M13.73%-9.78M21.57%-10.57M
Income tax
Net income 29.51%-9.64M-22.44%-51.21M-19.55%-11.96M-17.08%-11.45M-33.73%-14.13M-19.12%-13.68M36.01%-41.82M58.89%-10M13.73%-9.78M21.57%-10.57M
Net income continuous Operations 29.51%-9.64M-22.44%-51.21M-19.55%-11.96M-17.08%-11.45M-33.73%-14.13M-19.12%-13.68M36.01%-41.82M58.89%-10M13.73%-9.78M21.57%-10.57M
Minority interest income
Net income attributable to the parent company 29.51%-9.64M-22.44%-51.21M-19.55%-11.96M-17.08%-11.45M-33.73%-14.13M-19.12%-13.68M36.01%-41.82M58.89%-10M13.73%-9.78M21.57%-10.57M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 29.51%-9.64M-22.44%-51.21M-19.55%-11.96M-17.08%-11.45M-33.73%-14.13M-19.12%-13.68M36.01%-41.82M58.89%-10M13.73%-9.78M21.57%-10.57M
Basic earnings per share 67.12%-0.73-11.47%-7.5811.66%-1.44-10.69%-1.76-31.98%-2.27-23.33%-2.2237.90%-6.859.75%-1.6318.46%-1.5923.56%-1.72
Diluted earnings per share 67.12%-0.73-11.47%-7.5811.66%-1.44-10.69%-1.76-31.98%-2.27-23.33%-2.2237.90%-6.859.75%-1.6318.46%-1.5923.56%-1.72
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg